Aminosalicylates target GPR35, partly contributing to the prevention of DSS-induced colitis.

MLA

Otkur, Wuxiyar, et al. “Aminosalicylates Target GPR35, Partly Contributing to the Prevention of DSS-Induced Colitis.” European Journal of Pharmacology, vol. 949, June 2023, p. 175719. EBSCOhost, https://doi.org/10.1016/j.ejphar.2023.175719.

APA

Otkur, W., Wang, J., Hou, T., Liu, F., Yang, R., Li, Y., Xiang, K., Pei, S., Qi, H., Lin, H., Zhou, H., Zhang, X., Piao, H.-L., & Liang, X. (2023). Aminosalicylates target GPR35, partly contributing to the prevention of DSS-induced colitis. European Journal of Pharmacology, 949, 175719. https://doi.org/10.1016/j.ejphar.2023.175719

Chicago

Otkur, Wuxiyar, Jixia Wang, Tao Hou, Fan Liu, Renyu Yang, Yirong Li, Kaijing Xiang, et al. 2023. “Aminosalicylates Target GPR35, Partly Contributing to the Prevention of DSS-Induced Colitis.” European Journal of Pharmacology 949 (June): 175719. doi:10.1016/j.ejphar.2023.175719.